Kim EJ, Min HK, Choi YG, eds. Diabetes. 3rd ed. Seoul: Goryeo-euhak 2005:169–173, 830–832.

Pickup JC, Williams G. Diagnosis and treatment of diabetes mellitus. KMS 2006:1–6, 437–442.

Bowman WC, Rand MJ. Endocrine function of the pancreas. In: Textbook of pharmacology. 2nd ed. London: Blackwell Scientific Publications; 1980:1943–1964.

Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103–117.

UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–853.

UK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 1998;352:854–865.

Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–412.

Rohlfing CL, Wiedmeyer HM, Little RR, England JD, Tennil A, Goldstein DE. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. Diabetes Care 2002;25:275–278.

Riddle MC. Glycemic management of type 2 diabetes: an emerging strategy with oral agents, insulins, and combinations. Endocrinol Metab Clin North Am 2005;34:77–98.

Van Gaal LF, De Leeuw IH. Rationale and options for combination therapy in the treatment of type 2 diabetes. Diabetologia 2003;46(Suppl 1):M44–M50.

Yoon KH, Shin JA, Kwon HS, Lee SH, Min KW, Ahn YB, et al. Comparison of the efficacy of glimepiride, metformin, and rosiglitazone monotherapy in Korean drug-naive type 2 diabetic patients: the practical evidence of Antidiabetic Monotherapy Study. Diabetes Metab J 2011;35:26–33.

Canadian Diabetes Association 2003 Clinical Practice Guidelines for the Prevention and Management of Diabetes in Canada. Can J Diabetes 2003;27(Suppl 2):S58–S65.

Park SM. Types, effects and side effects of insulin. Korean Association of Diabetes Mellitus. Diabetes Mellitus 2006;10–11.

Jung SI, Kim JW. Clinical study about the diabetes mellitus patients. Administration of Yangkyuksanwha-tang. Kor J Ori Physiol Pathol 2002;16:1308–1313.

Choi BI, Ko BH, Song IB. Effects of Soyanginyanggueksanwhatang, indongduenjigolpitan and Sookjiwhanggosamtang on the alloxan-iInduced diabetic rats. Kyung Hee Univ Orient Med J 1992;15:113–133.

Kim EJ, Kim YS. Effects of Yanggyuksanhwa-tang on diabetic rats induced by streptozotocin. Kor J Ori Physiol Pathol 2007;21:474–478.

Guan L, Feng H, Gong D, Zhao X, Cai L, Wu Q, et al. Genipin ameliorates age-related insulin resistance through inhibiting hepatic oxidative stress and mitochondrial dysfunction. Exp Gerontol 2013 Sep 14. doi: 10.1016/j.exger.2013.09.001.Epub ahead of print.

Kojima K, Shimada T, Nagareda Y, Watanabe M, Ishizaki J, Sai Y, et al. Preventive effect of geniposide on metabolic disease status in spontaneously obese type 2 diabetic mice and free fatty acid-treated HepG2 cells. Biol Pharm Bull 2011;34:1613–1618.

Kim CJ, Cho SK, Shin MS, Cho H, Ro DS, Park JS, et al. Hypoglycemic activity of medicinal plants. Arch Pharm Res 1990;13:371–373.

Miura T, Ichiki H, Hashimoto I, Iwamoto N, Kato M, Kubo M, et al. Antidiabetic activity of a xanthone compound, mangiferin. Phytomedicine 2001;8:85–87.

Ichiki H, Miura T, Kubo M, Ishihara E, Komatsu Y, Tanigawa K, et al. New antidiabetic compounds, mangiferin and its glucoside. Biol Pharm Bull 1998;21:1389–1390.

Liu YW, Zhu X, Lu Q, Wang JY, Li W, Wei YQ, et al. Total saponins from Rhizoma Anemarrhenae ameliorate diabetes-associated cognitive decline in rats: involvement of amyloid-beta decrease in brain. J Ethnopharmacol 2012;139:194–200.

Lau KM, Lai KK, Liu CL, Tam JC, To MH, Kwok HF, et al. Synergistic interaction between Astragali Radix and Rehmanniae Radix in a Chinese herbal formula to promote diabetic wound healing. J Ethnopharmacol 2012;141:250–256.

Or PM, Lam FF, Kwan YW, Cho CH, Lau CP, Yu H, et al. Effects of Radix Astragali and Radix Rehmanniae, the components of an anti-diabetic foot ulcer herbal formula, on metabolism of model CYP1A2, CYP2C9, CYP2D6, CYP2E1 and CYP3A4 probe substrates in pooled human liver microsomes and specific CYP isoforms. Phytomedicine 2012;19:535–544.